Researchers develop new process to differentiate stem cells

April 17, 2018 by Erika Ebsworth-Goold, Washington University in St. Louis
Researchers at Washington University have developed a new way to transform human induced pluripotent stem cells (hiPSC) into nucleus pulposus cells, which are the chief component of intervertebral discs. This image shows day 36 of the differentiation process, as the hiPSCs are cultured with nucleus pulposus differentiation media. Credit: Setton Lab, Washington University in St. Louis

Neck and back pain are debilitating and expensive: an estimated 80 percent of adults will suffer one or both at some point during their lives, racking up $86 billion in medical costs and missed work in the United States alone. Often, the conditions are caused by the breakdown of discs, the load-bearing, donut-like structures that cushion the bones of the spine and are made mostly of a tissue called nucleus pulposus. Nucleus pulposus can degenerate with age, causing the discs to lose their shape and collapse—resulting in pain, among other problems.

As scientists try to find early therapy options to fight , there has been considerable interest in harnessing stem cells to restore , or NP. Previous research shows human induced (hiPSCs)—generated directly from adult cells—can express markers for a wide variety of cells, including those that secrete NP.

Now, a collaborative team of scientists at Washington University in St. Louis has developed a new process to generate NP-like cells from hiPSCs, one that truly goes back to the beginning and mimics the process of embryonic development.

"What we did here is study developmental biology first before we designed our experiment," said Lori Setton, the Lucy & Stanley Lopata Distinguished Professor of Biomedical Engineering and chair of the Department of Biomedical Engineering in the School of Engineering & Applied Science. "That was what was different in this particular study, we created a differentiation protocol to mimic ."

In past projects, scientists have tried to derive various types of differentiated cells from stem cells—such as bone, tissue, nerves or fat—directly from hiPSCs. Setton and her group backtracked, devising a series of steps to first produce one of the earliest-forming embryonic structures, the notochord. In humans, the notochord is a cartilage-like rod that turns into the spinal column during in-vitro development.

"We know that the intervertebral discs arise from the notochord," Setton said. "We decided to go back to the beginning and see if we could convert to be notochordal cells. Only after passing through the notochordal phase did we take them on to the intervertebral disc phase."

Human iPSCs were promoted to form nucleus pulposus-like cells of the intervertebral disc, following directed differentiation with defined media to promote mesodermal and then notochordal lineages. Periods of pellet culture in supplemented media promoted expression of the vacuolated cell morphology of the healthy nucleus pulposus cell. This differentiation protocol suggests utility for iPSCs in the regeneration and treatment of intervertebral disc pathology. Credit: Setton Lab, Washington University in St. Louis

Setton's team worked in collaboration with Farshid Guilak, professor of orthopaedic surgery at Washington University School of Medicine in St. Louis and director of research at Shriners Hospitals for Children-St. Louis, during an extensive three-year study process.

Setton's lab exposed the hiPSCs to a variety of different growth factors and culture media to coax them into first developing markers for, and then fully forming into, notochord cells. Once the scientists had the notochord cells, they used a similar chemical exposure process to develop those into NP-type cells. The lab tracked the differentiating process using fluorescent cell imaging, which tested for the necessary markers during each step. Their research was recently published in the journal Stem Cell Research & Therapy.

"You can think of it as a push-pull," Setton said. "You can push it in one direction, but you have to pull it from the other direction as well. I could push it toward a nerve, but I have to pull it from becoming bone. We didn't know what combination would work. It's like cooking in the kitchen, and you have to add things to the gravy. It took us a really long time to figure out that perfect recipe. But now that we did, it's very repeatable."

Setton says the multistep process her lab used to derive NP-type from the hiPSCs provides the necessary quality control as scientists seek additional uses for .

"If you think about a regulated medical product, we need to categorize it at each stage of its use and at each stage of its development," she said. "Just as if you're manufacturing an automotive part, you do quality control at every stage. That's what we did here."

Setton says the research's next steps include assessing environmental cues—such as the stiffness of the culture surface, cell topography and how a cell attaches—and observe their effects in transforming hiPSCs.

Explore further: Bioengineers develop new approach to regenerate back discs

More information: Ruhang Tang et al, Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells, Stem Cell Research & Therapy (2018). DOI: 10.1186/s13287-018-0797-1

Related Stories

Bioengineers develop new approach to regenerate back discs

July 16, 2013
Cell therapies may stop or reverse the pain and disability of degenerative disc disease and the loss of material between vertebrae, according to Duke University scientists.

Stem cells therapy for naturally occurring intervertebral disc disease

May 9, 2017
The intervertebral disc is the "shock absorber" between the vertebrae of the spine, cushioning every step, bend and jump. If the fibrocartilage tissue in the spine degenerates over time, an intervertebral disc can "slip" ...

Recommended for you

Enzyme identified as possible novel drug target for sickle cell disease, Thalassemia

July 19, 2018
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments ...

Mice given metabolite succinate found to lose weight by turning up the heat

July 19, 2018
A team of researchers with members from institutions across the U.S. and Canada has found that giving the metabolite succinate to mice fed a high-fat diet prevented obesity. In their paper published in the journal Nature, ...

Supplement may ease the pain of sickle cell disease

July 19, 2018
(HealthDay)—An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows.

Scientists uncover DNA 'shield' with crucial roles in normal cell division

July 18, 2018
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

Researchers develop novel bioengineering technique for personalized bone grafts

July 18, 2018
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique, described in a paper published ...

Researchers report protein kinase as the switch controlling obesity and diabetes

July 18, 2018
One of the research lines targeting the worldwide obesity epidemic is the manipulation of brown adipose tissue, a 'good' type of fat that burns lipids to maintain an appropriate body temperature. Researchers at the Centro ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.